Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 5/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | CASP7 | P55210 | 2/20 | 0.64 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.64 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.64 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 6/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.57 |
| ▸ | USP2 | O75604 | 4/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lumichrome SCHEMBL29516827 | 1.00 | BLM (0.64) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| Lumichrome SCHEMBL29861572 | 1.00 | BLM (0.64) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL10051618 | 0.88 | BLM (0.54) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL26498586 | 0.85 | BLM (0.51) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL498701 | 0.83 | TDP1 (0.66) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL498444 | 0.83 | TDP1 (0.66) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL11386760 | 0.82 | KDM4E (0.64) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL18048111 | 0.82 | KDM4E (0.64) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL23908716 | 0.81 | KDM4E (0.77) | BLMTDP1KDM4ECYP1A2ALDH1A1 | |
| Alloxazine SCHEMBL499075 | 0.78 | KDM4E (1.00) | BLMTDP1KDM4ECYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4297723-B1 | MICRONEEDLE COMPOSITIONS AND METHODS OF DELIVERY USING THE SAME | BRIGHAM & WOMENS HOSPITAL INC (US) | 2026-05-20 | — | — | EP | claimed |
| US-12571758-B2 | Glucose redox reaction and composition for glucose measurement using flavin compound | KIKKOMAN CORPORATION (JP) | 2026-03-10 | — | — | US | claimed |
| US-12376601-B2 | Systems and method for removing the yellow color of riboflavin from lactose solutions | SPX FLOW TECHNOLOGY DANMARK A/S (DK) | 2025-08-05 | — | — | US | claimed |
| EP-3976197-B1 | THERAPEUTICS AND METHODS FOR PREDICTING AND OVERCOMING ENDOCRINE RESISTANCE IN BREAST CANCER | LUNELLA BIOTECH INC (CA) | 2025-07-16 | — | — | EP | claimed |
| WO-2025122600-A1 | COMPOSITIONS AND METHODS FOR TREATING ABERRANT NITROSYLATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2025-06-12 | — | — | WO | claimed |
| EP-3934594-B1 | ENERGY AUGMENTATION STRUCTURES FOR USE IN NON-INVASIVE IN-SITU PHOTOBIOMODULATION | IMMUNOLIGHT LLC (US) | 2025-05-28 | — | — | EP | claimed |
| US-20250161314-A1 | METHOD FOR TREATMENT OR IMPROVEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND OBESITY BY LUMICHROME | CATHAY GENERAL HOSPITAL (TW) | 2025-05-22 | — | — | US | claimed |
| WO-2025101956-A2 | CONTROL OF ENZYMATIC NUCLEIC ACID SYNTHESIS VIA ELECTROCHEMICAL MEANS | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| US-20250143897-A1 | STENT-CONTAINING MEDICAL DEVICES AND METHODS OF USING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-05-08 | — | — | US | claimed |
| EP-0739208-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1996-10-30 | — | — | EP | claimed |
| WO-1995011028-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1995-04-27 | — | — | WO | claimed |
| US-5300428-A | Adding electrochemically reducible, consumable indicator to nutrient solution, detecting change in electrical properties with immersed electrodes | CMB PACKAGING (UK) LIMITED (GB) | 1994-04-05 | — | — | US | claimed |
| US-5153236-A | Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images | HITACHI CHEMICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | claimed |
| US-5126247-A | For enzymatic colorimatic measurement of presence or concentration of analytes in samples of animal fluids; medical diagnosis | ENZYMATICS, INC. (US) | 1992-06-30 | — | — | US | claimed |
| EP-0242527-B1 | ANALYTE DETECTION BY MEANS OF ENERGY TRANSFER | ENZO BIOCHEM, INC. (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0397362-A1 | Electrochemical detection of growth of micro-organisms | CarnaudMetalbox plc (GB) | 1990-11-14 | — | — | EP | claimed |
| US-4868103-A | Analyte detection by means of energy transfer | ENZO BIOCHEM, INC. (US) | 1989-09-19 | — | — | US | claimed |
| EP-0330517-A2 | Method, system and devices for the assay and detection of biochemical molecules | SOLARCARE TECHNOLOGIES CORPORATION (US) | 1989-08-30 | — | — | EP | claimed |
| EP-0242527-A2 | Analyte detection by means of energy transfer | ENZO BIOCHEM, INC. (US) | 1987-10-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12571758-B2 | Glucose redox reaction and composition for glucose measurement using flavin compound | G6PD, TKFC, UGDH | BLM 3476/4885TDP1 890/4885KDM4E 2470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.